Table 3.
Post intervention impact on primary and secondary outcomes.
| Variables | Group I N (53) | Group II N (76) | P value† |
|---|---|---|---|
| PRIMARY OUTCOME | |||
| HbA1c(%) | |||
| At I year | 8.79 ± 1.81 | 8.18 ± 1.32 | 0.0238* |
| Mean change from baseline | −1.42 | −2.64 | |
| SECONDARY OUTCOMES | |||
| FPG | |||
| At I year | 158 ± 44.5 | 144.7 ± 43.8 | 0.0765 |
| Mean change from baseline | −37.66 | −68.88 | |
| PPG | |||
| At I year | 200.9 ± 82.4 | 213.4 ± 67.3 | 0.4921 |
| Mean change from baseline | −66.45 | −79.64 | |
| SBP | |||
| At I year | 120.89 ± 13.9 | 124.32 ± 15.9 | 0.0365 |
| Mean change from baseline | −0.81 | 1.34 | |
| DBP | |||
| At I year | 77.26 ± 9.1 | 77.16 ± 10 | 0.8559 |
| Mean change from baseline | −0.8491 | 0.54 | |
| HDL | |||
| At I year | 41.11 ± 11.7 | 38.46 ± 9.8 | 0.3364 |
| Mean change from baseline | 1.89 | −2.73 | |
| LDL | |||
| At I year | 104.58 ± 27.4 | 102.48 ± 32.9 | 0.3158 |
| Mean change from baseline | −15.43 | −15.12 | |
| TGL | |||
| At I year | 158.74 ± 81.9 | 161.27 ± 10.5 | 0.7702 |
| Mean change from baseline | 3.26 | −13.71 | |
| Body Wt | |||
| At I year | 77.42 ± 13.2 | 82.73 ± 15.3 | 0.1793 |
| Mean change from baseline | −0.46 | 4.48 | |
| BMI | |||
| At I year | 29.59 ± 4.6 | 32.34 ± 6.6 | 0.0421* |
| Mean change from baseline | −0.16 | 1.78 | |
| % of patients achieved HbA1c target—no (%) | |||
| ≤ 7% | 11 (20.8) | 23 (30.3) | |
| Hypoglycemic incidences | 6(11.3) | 18 (23.7) | |
Values are presented as n (%) or mean – SD.
†
The p values are for the comparisons between the groups at 1 year.
*
P values < 0.05 are statistically significant.